Milestone Pharmaceuticals, a Canadian company with a U.S. subsidiary in Charlotte, is back on track with a potential drug to treat rapid heart rates in certain cardiovascular disorders.The company in late March re-submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval of etripamil for the management of paroxysmal supraventricular tachycardia (PSVT), a type of arrhythmia or abnormal heart rhythm.
There's another Pappas working at Pappas Capital, but the venture capital firm is quick to point out that Nick Pappas is "no relation" to the firm's founder Art Pappas.
/PRNewswire/ Pappas Capital, a leading investor in next-generation life science and technology companies, announced today that Nick Pappas (no relation) has.
Mianus Capital (Mianus) and its strategic partner MERIT CRO, Inc. (MERIT) announced at the Association for Research in Vision and Ophthalmology (ARVO) 2023
PAPPAS CAPITAL STRENGTHENS TEAM WITH APPOINTMENT OF W RICHARD STAUB AS VENTURE PARTNER streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.